EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effects of single and multiple resistance mechanisms on bacterial response to meropenem

Dominika T Fuhs, Sara Cortés-Lara, Jessica R Tait, Kate E Rogers, Carla López-Causapé, Wee Leng Lee, David M Shackleford, Roger L Nation, Antonio Oliver, Cornelia B Landersdorfer

Clinical Microbiology and Infection · 2024

DOI: 10.1016/j.cmi.2024.06.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Dominika T Fuhs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Meropenem, Microbial Sensitivity Tests, Anti-Bacterial Agents, Pseudomonas aeruginosa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Meropenem is commonly used against Pseudomonas aeruginosa. Traditionally, the time unbound antibiotic concentration exceeds the MIC (fT>MIC) is used to select carbapenem regimens. We aimed to characterize the effects of different baseline resistance mechanisms on bacterial killing and resistance emergence; evaluate whether fT>MIC can predict these effects; and, develop a novel Quantitative and Systems Pharmacology (QSP) model to describe the effects of baseline resistance mechanisms on the time-course of bacterial response. METHODS: Seven isogenic P. aeruginosa strains with a range of resistance mechanisms and MICs were used in 10-day hollow-fiber infection model studies. Meropenem pharmacokinetic profiles were simulated for various regimens (t1/2,meropenem = 1.5 h). All viable counts on drug-free, 3 × MIC, and 5 × MIC meropenem-containing agar across all strains, five regimens, and control (n = 90 profiles) were simultaneously subjected to QSP modeling. Whole genome sequencing was completed for total population samples and emergent resistant colonies at 239 h. RESULTS: Regimens achieving ≥98%fT>1×MIC suppressed resistance emergence of the mexR knockout strain. Even 100%fT>5 × MIC failed to achieve this against the strain with OprD loss and the ampD and mexR double-knockout strain. Baseline resistance mechanisms affected bacterial outcomes, even for strains with the same MIC. Genomic analysis revealed that pre-existing resistant subpopulations drove resistance emergence. During meropenem exposure, mutations in mexR were selected in strains with baseline oprD mutations, and vice versa, confirming these as major mechanisms of resistance emergence. Secondary mutations occurred in lysS or argS, coding for lysyl and arginyl tRNA synthetases, respectively. DISCUSSION: The QSP model well-characterized all bacterial outcomes of the seven strains simultaneously, which fT>MIC could not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemMicrobial Sensitivity TestsAnti-Bacterial AgentsPseudomonas aeruginosaHumansDrug Resistance, Multiple, BacterialPseudomonas InfectionsDrug Resistance, BacterialWhole Genome Sequencing

Stichwörter der Autor:innen

Antibiotic resistancePopulation genomicsPseudomonas aeruginosaQuantitative systems pharmacologyWhole genome sequencing

Substanzen

MeropenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Servicio de Microbiología, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
  • Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia. Electronic address: cornelia.landersdorfer@monash.edu.

Zitieren

APA

Fuhs, D. T., Cortés-Lara, S., Tait, J. R., Rogers, K. E., López-Causapé, C., Lee, W. L., Shackleford, D. M., Nation, R. L., Oliver, A., & Landersdorfer, C. B. (2024). The effects of single and multiple resistance mechanisms on bacterial response to meropenem. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.06.026

Vancouver

Fuhs DT, Cortés-Lara S, Tait JR, Rogers KE, López-Causapé C, Lee WL, et al. The effects of single and multiple resistance mechanisms on bacterial response to meropenem. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.06.026

BibTeX
@article{Fuhs2024,
  author = {Fuhs, Dominika T and Cortés-Lara, Sara and Tait, Jessica R and Rogers, Kate E and López-Causapé, Carla and Lee, Wee Leng and Shackleford, David M and Nation, Roger L and Oliver, Antonio and Landersdorfer, Cornelia B},
  title = {The effects of single and multiple resistance mechanisms on bacterial response to meropenem},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  doi = {10.1016/j.cmi.2024.06.026}
}
Kostenlos starten →